TY - JOUR
T1 - Clinical phenotype of the recurrent 1q21.1 copy-number variant
AU - on behalf of the Simons VIP consortium
AU - Bernier, Raphael
AU - Steinman, Kyle J.
AU - Reilly, Beau
AU - Wallace, Arianne Stevens
AU - Sherr, Elliott H.
AU - Pojman, Nicholas
AU - Mefford, Heather C.
AU - Gerdts, Jennifer
AU - Earl, Rachel
AU - Hanson, Ellen
AU - Goin-Kochel, Robin P.
AU - Berry, Leandra
AU - Kanne, Stephen
AU - Snyder, Leeanne Green
AU - Spence, Sarah
AU - Ramocki, Melissa B.
AU - Evans, David W.
AU - Spiro, John E.
AU - Martin, Christa L.
AU - Ledbetter, David H.
AU - Chung, Wendy K.
AU - Alupay, H.
AU - Aaronson, B.
AU - Ackerman, S.
AU - Ankenmann, K.
AU - Atwell, C.
AU - Aylward, E.
AU - Beaudet, A.
AU - Benedetti, M.
AU - Berman, J.
AU - Bernier, R.
AU - Bibb, A.
AU - Blaskey, L.
AU - Brewton, C.
AU - Buckner, R.
AU - Bukshpun, P.
AU - Burko, J.
AU - Cerban, B.
AU - Chen, Q.
AU - Cheong, M.
AU - Chu, Z.
AU - Dale, C.
AU - Dempsey, A.
AU - Elgin, J.
AU - Olson, J.
AU - Evans, Y.
AU - Faucett, W. A.
AU - Fischbach, G.
AU - Garza, S.
AU - Gerdts, J.
N1 - Funding Information:
This work was supported by two grants from the Simons Foundation (SFARI award 198677 to R.B., E.H., R.G.K., and W.K.C., and SFARI award 312100 to C.L.M., D.H.L.) and a grant from the National Institutes of Health (MH074090 to D.H.L. and C.L.M.). We are grateful to all the families at the participating Simons Variation in Individuals Project (Simons VIP) sites, as well as the Simons VIP working group (Simons VIP consortium, Neuron, 73:1063'1067, 2012).
Publisher Copyright:
© American College of Medical Genetics and Genomics.
PY - 2016/4/1
Y1 - 2016/4/1
N2 - Purpose:To characterize the clinical phenotype of the recurrent copy-number variation (CNV) at 1q21.1, we assessed the psychiatric and medical phenotypes of 1q21.1 deletion and duplication carriers ascertained through clinical genetic testing and family member cascade testing, with particular emphasis on dimensional assessment across multiple functional domains.Methods:Nineteen individuals with 1q21.1 deletion, 19 individuals with the duplication, and 23 familial controls (noncarrier siblings and parents) spanning early childhood through adulthood were evaluated for psychiatric, neurologic, and other medical diagnoses, and their cognitive, adaptive, language, motor, and neurologic domains were also assessed. Twenty-eight individuals with 1q21.1 CNVs (15 deletion, 13 duplication) underwent structural magnetic resonance brain imaging.Results:Probands with 1q21.1 CNVs presented with a range of psychiatric, neurologic, and medical disorders. Deletion and duplication carriers shared several features, including borderline cognitive functioning, impaired fine and gross motor functioning, articulation abnormalities, and hypotonia. Increased frequency of Autism Spectrum Disorder (ASD) diagnosis, increased ASD symptom severity, and increased prevalence of macrocephaly were observed in the duplication relative to deletion carriers, whereas reciprocally increased prevalence of microcephaly was observed in the deletion carriers.Conclusions:Individuals with 1q21.1 deletions or duplications exhibit consistent deficits on motor and cognitive functioning and abnormalities in head circumference.Genet Med 18 4, 341-349.
AB - Purpose:To characterize the clinical phenotype of the recurrent copy-number variation (CNV) at 1q21.1, we assessed the psychiatric and medical phenotypes of 1q21.1 deletion and duplication carriers ascertained through clinical genetic testing and family member cascade testing, with particular emphasis on dimensional assessment across multiple functional domains.Methods:Nineteen individuals with 1q21.1 deletion, 19 individuals with the duplication, and 23 familial controls (noncarrier siblings and parents) spanning early childhood through adulthood were evaluated for psychiatric, neurologic, and other medical diagnoses, and their cognitive, adaptive, language, motor, and neurologic domains were also assessed. Twenty-eight individuals with 1q21.1 CNVs (15 deletion, 13 duplication) underwent structural magnetic resonance brain imaging.Results:Probands with 1q21.1 CNVs presented with a range of psychiatric, neurologic, and medical disorders. Deletion and duplication carriers shared several features, including borderline cognitive functioning, impaired fine and gross motor functioning, articulation abnormalities, and hypotonia. Increased frequency of Autism Spectrum Disorder (ASD) diagnosis, increased ASD symptom severity, and increased prevalence of macrocephaly were observed in the duplication relative to deletion carriers, whereas reciprocally increased prevalence of microcephaly was observed in the deletion carriers.Conclusions:Individuals with 1q21.1 deletions or duplications exhibit consistent deficits on motor and cognitive functioning and abnormalities in head circumference.Genet Med 18 4, 341-349.
KW - 1q21.1 deletion
KW - 1q21.1 duplication
KW - autism spectrum disorder
KW - copy-number variation
KW - developmental disability
UR - http://www.scopus.com/inward/record.url?scp=84962527356&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84962527356&partnerID=8YFLogxK
U2 - 10.1038/gim.2015.78
DO - 10.1038/gim.2015.78
M3 - Article
C2 - 26066539
AN - SCOPUS:84962527356
SN - 1098-3600
VL - 18
SP - 341
EP - 349
JO - Genetics in Medicine
JF - Genetics in Medicine
IS - 4
ER -